In this issue:
Australia bans vaping
Inhalable sensors may enable early lung cancer diagnosis with a urine test
APPLE: osimertinib vs gefitinib/osimertinib in advanced EGFR-mutated NSCLC
Rates of invasive procedures following lung cancer screening may be higher than thought
Osimertinib consolidation beneficial in inoperable EGFR-mutated NSCLC
Ficonalkib promising for ALK-positive NSCLC resistant to second-generation ALK TKIs
PBAC recommendations
Upcoming PBAC agenda
PBS listings
Updates from the FDA
ANORAK improves histopathological grading of lung adenocarcinoma
INSPIRE supports front-line iruplinalkib for ALK positive NSCLC
2024 TROG Annual Scientific Meeting
Mirtazapine may improve lung cancer-related anorexia
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)